HH
Hossein Habibinejad
Head Of Investment Development And Planning at Arman Tose'E Mobin Mehr Sepehr
View Hossein's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Head Of Investment Development And Planning
Jun 2023 - Present · 1 years and 6 months
Self-employed
Analyst Equity Capital Market
Feb 2019 - Present · 5 years and 10 months
Property Asset Manager
Mar 2021 - Apr 2023 · 2 years and 1 months
Company Details
Arman Tose'e Mobin Mehr Sepehr Company was registered in 2022 in the Register of Companies and Non-Commercial Institutions of Tehran. Currently, this company is one of the subsidiary business units of Sepehr Saderat Financial Group, and the final business unit is Bank Saderat Iran. The subject of Arman Tose'e Mobin Mehr Sepehr activities are: • Creating or participating in the establishment and launch of manufacturing, service and commercial companies; • Buying and acquiring shares of manufacturing, commercial and service companies; • Investing in oil, petrochemical and chemical projects and providing equipment needed in oil, gas and energy industries; • Exploration, extraction, production and supply of all kinds of metallic and non-metallic minerals, metallic and non-metallic minerals and other products obtained from the processing of raw and semi-raw minerals. Future plans of the company: • Continuous growth of profitability; • Continuous improvement of financial reporting; • Continuous monitoring and exploitation of investment opportunities (paying attention to current technical knowledge and moving towards investment areas with high added value and knowledge-based); • Optimizing the asset portfolio and effective risk assessment;
Year Founded
--
Social Media
Linkedin
Industry
Financial Services
HQ Location
Tehran, IR
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Hossein Habibinejad in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.